Skip to main content
. 2021 Dec 15;13(12):2114–2128. doi: 10.4251/wjgo.v13.i12.2114

Figure 6.

Figure 6

Propofol attenuates gastric cancer progression by miR-125b-5p/STAT3 axis. A–C: SGC7901 and BGC823 cells were treated propofol, or cotreated with propofol and miR-125b-5p inhibitor or pcDNA.1-STAT3. A and B: MTT assays analyzed the cell viability; C: Flow cytometry measured apoptosis. n = 3, mean ± SD, bP < 0.01.